bf/NYSE:LLY_icon.png

NYSE:LLY

Eli Lilly and Company

  • Stock

USD

Last Close

937.44

06/11 22:20

Market Cap

893.17B

Beta: 0.36

Volume Today

11.69M

Avg: 3.30M

PE Ratio

127.25

PFCF: −4,061.24

Dividend Yield

0.64%

Payout:78.90%

OverviewFinancialsAPI

    Description

    Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    123452017-07-252019-07-302021-08-032023-08-082024-10-30

    Revenue (Estimate*)

    2B4B6B8B10B12B14B2017-07-252019-07-302021-08-032023-08-082024-10-30

    *Estimate based on analyst consensus